Benzinga's Top #PreMarket Losers

By: via Benzinga
Synta Pharmaceuticals (NASDAQ: SNTA) shares dropped 21.40% to $4.15 in pre-market trading after gaining 4.35% on Tuesday. Stifel ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.